ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 852 filers reported holding ISHARES TR in Q2 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,013,519 | -2.7% | 7,847 | -1.1% | 0.68% | -7.6% |
| Q4 2022 | $1,042,049 | +8.8% | 7,937 | -3.1% | 0.73% | +9.1% |
| Q3 2022 | $958,000 | -4.6% | 8,192 | -4.0% | 0.67% | +1.7% |
| Q2 2022 | $1,004,000 | -12.2% | 8,537 | -2.7% | 0.66% | +5.6% |
| Q1 2022 | $1,144,000 | -15.9% | 8,777 | -1.6% | 0.63% | -13.6% |
| Q4 2021 | $1,361,000 | -7.1% | 8,917 | -1.6% | 0.73% | -13.8% |
| Q3 2021 | $1,465,000 | +19.8% | 9,059 | +0.3% | 0.84% | -17.5% |
| Q3 2020 | $1,223,000 | +7.8% | 9,029 | +8.7% | 1.02% | -0.3% |
| Q2 2020 | $1,135,000 | +22.7% | 8,304 | -3.3% | 1.02% | -3.6% |
| Q1 2020 | $925,000 | -8.7% | 8,589 | +2.2% | 1.06% | +18.9% |
| Q4 2019 | $1,013,000 | +16.3% | 8,404 | -4.0% | 0.89% | +8.6% |
| Q3 2019 | $871,000 | -10.6% | 8,754 | -2.0% | 0.82% | -11.7% |
| Q2 2019 | $974,000 | -10.6% | 8,929 | -3.0% | 0.93% | -17.1% |
| Q2 2018 | $1,090,000 | +15.2% | 9,209 | +3.9% | 1.12% | -10.1% |
| Q1 2018 | $946,000 | – | 8,867 | – | 1.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |